Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-16

Clinical Trial Update: Vasopressin and Pain Perception in the Brain [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study investigates whether vasopressin affects brain-based pain perception in adults with acute pain; results were posted in December 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Acute Pain | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-12-16